Literature DB >> 1937684

Role of sympathetic efferent nerves in blood pressure regulation and in hypertension.

C J Mathias1.   

Abstract

This article presents some aspects of the role of sympathetic efferent nerves in the regulation of blood pressure in humans. Lessons have been learned from disorders that cause either sympathetic underactivity or overactivity. In chronic autonomic failure, pressor stimuli (mental arithmetic, isometric exercise, or cold) are unable to raise blood pressure, whereas stimuli that normally activate sympathetic efferent nerves to maintain blood pressure (head-up tilt, exercise, and food ingestion) can cause marked hypotension. Recognition of specific defects, such as the inability to synthesize norepinephrine in isolated dopamine beta-hydroxylase deficiency, suggests that sympathetic nerves may influence blood pressure regulation through nonadrenergic mechanisms (dopamine, neuropeptides, and purines). Tetraplegic patients with high cervical cord transection also have sympathetic impairment and postural hypotension, but this is less of a clinical problem because of compensatory hormonal and other mechanisms. Tetraplegic patients are unique as they also may have severe paroxysmal hypertension because of increased spinal sympathetic reflex activity. The pathophysiological mechanisms responsible for this exaggerated response include changes in postsynaptic adrenergic receptor numbers and their sensitivity, the actions of nonadrenergic cotransmitters, and the lack of sympathoneural pathways from the brain that are severed by the lesion. Finally, the putative role of the sympathetic nervous system in hypertension with unilateral renal artery stenosis, which initially is humorally mediated, is discussed. The centrally acting sympatholytic agent clonidine is effective in lowering blood pressure in renovascular hypertension independently of humoral factors when multiple agents have failed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1937684     DOI: 10.1161/01.hyp.18.5_suppl.iii22

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Cardiovascular and hormonal responses to food ingestion in humans with spinal cord transection.

Authors:  R R Baliga; A B Catz; L D Watson; D J Short; H L Frankel; C J Mathias
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

2.  Effects of decompressive operation on cardiac autonomic regulation in patients with cervical spondylotic myelopathy: analysis of blood pressure, heart rate, and heart rate variability.

Authors:  Peng Li; Zihan Wei; Haoping Zhang; Kainan Zhang; Junwei Li
Journal:  Eur Spine J       Date:  2019-04-22       Impact factor: 3.134

3.  Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  S L Demel; H Dong; G M Swain; X Wang; D L Kreulen; J J Galligan
Journal:  Neuroscience       Date:  2010-04-14       Impact factor: 3.590

4.  Redox-regulated suppression of splenic T-lymphocyte activation in a model of sympathoexcitation.

Authors:  Adam J Case; Matthew C Zimmerman
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

5.  Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers.

Authors:  Xian Cao; Stacie L Demel; Mark T Quinn; James J Galligan; David Kreulen
Journal:  Auton Neurosci       Date:  2009-08-27       Impact factor: 3.145

6.  Severe paroxysmal hypertension induced by a subconscious Valsalva-like manoeuvres.

Authors:  P E Nielsen; F Jørgensen; J Conway; P Sleight
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

7.  Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors.

Authors:  Manabu Kadoya; Hidenori Koyama; Masafumi Kurajoh; Mariko Naka; Akio Miyoshi; Akinori Kanzaki; Miki Kakutani; Takuhito Shoji; Yuji Moriwaki; Tetsuya Yamamoto; Masaaki Inaba; Mitsuyoshi Namba
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.